Article Information
History
- April 5, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Fernanda Caramella-Pereira1,
- Qizhi Zheng1,
- Jessica L. Hicks1,
- Sujayita Roy,
- Tracy Jones1,
- Martin Pomper5,
- Lizamma Antony3,
- Alan K. Meeker2,
- Srinivasan Yegnasubramanian4,
- Angelo M. De Marzo2,#,* and
- W. Nathaniel Brennen3,*
- 1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD,
- 2Department of Pathology, Oncology, and Urology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the James Buchanan Brady Urological Research Institute., Baltimore, MD,
- 3Department of Oncology, and Urology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the James Buchanan Brady Urological Research Institute., Baltimore, MD
- 4Department of Pathology, Oncology, and Urology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the James Buchanan Brady Urological Research Institute, Baltimore, MD
- 5University of Texas, Southwestern Medical Center, Dallas, TX
- ↵#Address for correspondence: A M De Marzo, MD, Department of Pathology, 1550 Orleans Street. CRB2, Rm144, Baltimore, Maryland, 410 614 5686 Main, 410 502 9817 Fax Email: ademarz{at}jhmi.edu
Posted April 05, 2024.
Overexpression of Fibroblast Activation Protein (FAP) in stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate
